[Immunisation schedule of the Spanish Association of Paediatrics: 2017 recommendations]

Insights

The Spanish Association of Paediatrics recommends optimal childhood immunisation schedules, including funded vaccines like pneumococcal and varicella, and advises on unfunded options such as rotavirus and meningococcal vaccines.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Public Health

Background:

  • The Spanish Association of Paediatrics' Advisory Committee on Vaccines (CAV-AEP) annually updates optimal childhood immunisation schedules for Spain.
  • Key childhood vaccines like pneumococcal and varicella are funded in regional programmes.
  • Recommendations extend to non-funded vaccines including rotavirus, meningococcal B, and meningococcal ACWY.

Purpose of the Study:

  • To outline the CAV-AEP's recommended optimal immunisation schedule for children in Spain.
  • To highlight funded and non-funded vaccination strategies.
  • To provide evidence-based recommendations for vaccine administration timing and coverage.

Main Methods:

  • Review of current evidence on vaccine efficacy and safety.
  • Analysis of existing funded and recommended non-funded vaccination programmes in Spain.
  • Formulation of a comprehensive immunisation schedule by the CAV-AEP.

Main Results:

  • Recommended funded schedule: 2+1 strategy (2, 4, 11-12 months) for hexavalent (DTaP-IPV-Hib-HB) and 13-valent pneumococcal vaccines.
  • Booster doses recommended for DTaP (6 years) and polio (Tdap vaccine for adolescents and pregnant women).
  • Two-dose schedules for MMR (12 months, 2-4 years) and varicella (15 months, 2-4 years).
  • Emphasis on improving human papillomavirus (HPV) vaccination coverage in 12-year-old girls and providing information to male adolescents.
  • ACWY meningococcal vaccine recommended for adolescents.
  • Meningococcal B vaccine recommended with a 3+1 scheme for unfunded immunisation.
  • Rotavirus vaccination recommended for all infants.

Conclusions:

  • The CAV-AEP provides an optimal immunisation schedule based on current evidence.
  • Improvements are needed in HPV vaccination coverage and adolescent recommendations.
  • The CAV-AEP advocates for the inclusion of meningococcal B vaccine in the funded schedule.

Related Concept Videos